Mobocertinib in EGFR Exon 20 InsertionePositive Metastatic NSCLC Patients With Disease Control on Prior EGFR TKI Therapy Meeting Abstract

Industry Collaboration

cited authors

  • Spira, A.; Ramalingam, S.; Neal, J.; Piotrowska, Z.; Mekhail, T.; Tsao, A.; Gentzler, R.; Riely, G.; Bazhenova, L.; Gadgeel, S.; Nguyen, D.; Johnson, M.; Vincent, S.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Churchill, E.; Mehta, M.; Janne, P.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

keywords

  • EGFR tyrosine kinase inhibitor
  • exon20 insertion
  • non-small cell lung cancer

start page

  • S873

end page

  • S874

volume

  • 16

issue

  • 10